Media Summary: Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ... This lecture by Dr. S.Y. Amy Cheung, a senior director of Integrated Drug Development at Certara, aligns the challenges of ...

Midd Training Module 4 Case - Detailed Analysis & Overview

Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ... This lecture by Dr. S.Y. Amy Cheung, a senior director of Integrated Drug Development at Certara, aligns the challenges of ... This lecture by Dr. S.Y. Amy Cheung, a Senior Director of Integrated Drug Development at Certara, discusses how top-down and ... Jeffrey Barrett from the Critical Path Institute provides the overview of this Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses model interconnectedness and how ...

Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses the role of modeling and simulation in ... This lecture by Jeffrey Barrett from the Critical Path Institute describes the Dr. Hoai-Thu Thai with Sanofi explains how Stacy Tannenbaum, lead of the Pharmacometrics Group in the US Dr. Jeff Barrett from the Critical path Institute describes the application of

Photo Gallery

MIDD Training Module 4 – Case Study 1: Decision Analysis to Support Drug Development
MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling
MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness
Module 4 – Case Study 4: Vaccine PKPD, MBMA, and Beyond
Module 4  Case Study 3 Pediatric Drug Development, Utilization of Top-Down and Bottom-Up Approaches
MIDD Training OVERVIEW
Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.
Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab
MIDD Training Module 1
Module 7 – Case Study 4: MIDD to Establish Isatuximab Combination Dosing Regimen
MIDD Training  Module 2 – Part One
MIDD Training Module 3 – Pediatric Drug Development Considerations
View Detailed Profile
MIDD Training Module 4 – Case Study 1: Decision Analysis to Support Drug Development

MIDD Training Module 4 – Case Study 1: Decision Analysis to Support Drug Development

Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development.

MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling

MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling

This lecture by Dr. Rajesh Krishna is a

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness

This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ...

Module 4 – Case Study 4: Vaccine PKPD, MBMA, and Beyond

Module 4 – Case Study 4: Vaccine PKPD, MBMA, and Beyond

This lecture by Dr. S.Y. Amy Cheung, a senior director of Integrated Drug Development at Certara, aligns the challenges of ...

Module 4  Case Study 3 Pediatric Drug Development, Utilization of Top-Down and Bottom-Up Approaches

Module 4 Case Study 3 Pediatric Drug Development, Utilization of Top-Down and Bottom-Up Approaches

This lecture by Dr. S.Y. Amy Cheung, a Senior Director of Integrated Drug Development at Certara, discusses how top-down and ...

MIDD Training OVERVIEW

MIDD Training OVERVIEW

Jeffrey Barrett from the Critical Path Institute provides the overview of this

Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.

Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.

Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses model interconnectedness and how ...

Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab

Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab

Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses the role of modeling and simulation in ...

MIDD Training Module 1

MIDD Training Module 1

This lecture by Jeffrey Barrett from the Critical Path Institute describes the

Module 7 – Case Study 4: MIDD to Establish Isatuximab Combination Dosing Regimen

Module 7 – Case Study 4: MIDD to Establish Isatuximab Combination Dosing Regimen

Dr. Hoai-Thu Thai with Sanofi explains how

MIDD Training  Module 2 – Part One

MIDD Training Module 2 – Part One

Stacy Tannenbaum, lead of the Pharmacometrics Group in the US

MIDD Training Module 3 – Pediatric Drug Development Considerations

MIDD Training Module 3 – Pediatric Drug Development Considerations

Dr. Jeff Barrett from the Critical path Institute describes the application of

Introduction to the MIDD Training Course

Introduction to the MIDD Training Course

Dr. Qi Liu, the Assoc. Director